COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1705: Articles 17041-17050  | Next

A pharmacophore model for SARS-CoV-2 3CLpro small molecule inhibitors and in vitro experimental validation of computationally screened inhibitors
Glaab, E., Manoharan, G. B., Abankwa, D.
10.1101/2021.03.02.433618 — Posted: 2021-03-03
Impact of COVID-19 pandemic on Black, Asian and Minority Ethnic (BAME) communities: a qualitative study on the perspectives of BAME community leaders
Mahmood, F., Acharya, D., Kumar, K., Paudyal, V.
10.1101/2021.03.03.21252286 — Posted: 2021-03-03
Modeling University Reopening in Low Risk Countries During COVID-19
Xi, J. Y., Chan, W. K.
10.1101/2021.03.02.21250607 — Posted: 2021-03-03
A novel, multiplexed RT-qPCR assay to distinguish lineage B.1.1.7 from the remaining SARS-CoV-2 lineages
Kovacova, V., Borsova, K., Paul, E. D., Radvanszka, M., Hajdu, R., Cabanova, V., Slavikova, M., Lickova, M., Lukacikova, L., Belak, A., Roussier, L., Kosticova, M., Liskova, A., Madarova, L., Stefkovicova, M., Reizigova, L., Novakova, E., Sabaka, P., Koscalova, A., Brejova, B., Vinar, T., Nosek, J., Cekan, P., Klempa, B.
10.1101/2021.02.09.21251168 — Posted: 2021-03-03
Recent Gains in Life Expectancy Reversed by the COVID-19 Pandemic
Aburto, J. M., Scholey, J., Zhang, L., Kashnitsky, I., Rahal, C., Missov, T., Mills, M. C., Dowd, J. B., Kashyap, R.
10.1101/2021.03.02.21252772 — Posted: 2021-03-03 Discussion: Onsite
Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco
Peng, J., Mann, S. A., Mitchell, A. M., Liu, J., Laurie, M. T., Sunshine, S., Pilarowski, G., Ayscue, P., Kistler, A., Vanaerschot, M., Li, L. M., McGeever, A., Chow, E. D., IDseq Team, , Marquez, C., Nakamura, R., Rubio, L., Chamie, G., Jones, D., Jacobo, J., Rojas, S., Tulier-Laiwa, V., Black, D., Martinez, J., Naso, J., Schwab, J., Petersen, M., Havlir, D., DeRisi, J. L.
10.1101/2021.03.01.21252705 — Posted: 2021-03-03
Atorvastatin effectively inhibits late replicative cycle steps of SARS-CoV-2 in vitro
Zapata-Cardona, M. I., Florez-Alvarez, L., Zapata-Builes, W., Guerra-Sandoval, A., Guerra-Almonacid, C., Hincapie-Garcia, J., Rugeles, M. T., Hernandez, J. C.
10.1101/2021.03.01.433498 — Posted: 2021-03-03
An overview of the National COVID-19 Chest Imaging Database: data quality and cohort analysis
Cushnan, D., Bennett, O., Berka, R., Bertolli, O., Chopra, A., Dorgham, S., Favaro, A., Ganepola, T., Halling-Brown, M., Imreh, G., Jacob, J., Jefferson, E., Lemarchand, F., Schofield, D., Wyatt, J. C., NCCID Collaborative
10.1101/2021.03.02.21252444 — Posted: 2021-03-03
Experiences of COVID-19 Recovered Patients - A Qualitative Case Study from a Hotspot in Saudi Arabia
Alhajjaji, A., Kurdi, A., Faqeh, S., Alansari, S., Abdulaziz, A., Allihyani, M., Almaghamsi, O., Cheema, E., Ali, M.
10.1101/2021.03.01.21252508 — Posted: 2021-03-03
365 days with COVID-19 in Iran: data analysis and epidemic curves
Sahafizadeh, E., Talatian Azad, S.
10.1101/2021.03.02.21252694 — Posted: 2021-03-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).